Button Contactform

Logo TissueGEN



The TissueGEN project focuses on the production of an in vitro human disease tissue platform technology to enable and accelerate the development of regenerative medicine therapies for a diverse range of diseases. The concept will be realized by the in vitro generation of 3D human tissues cultured from human induced Pluripotent Stem (iPS) cells. A bioreactor will be constructed using a range of innovative microfluidic techniques to produce systems compatible with analysis systems commonly used in laboratories worldwide (e.g. well plate format). The development of a platform technology producing 3D human tissue disease cultures will enable the generation of fully differentiated cell types and thus allow diseases to be effectively modeled at a population relevant scale in 3D human tissues in vitro. More information can be found on the project website www.tissuegen.org 

The research receives funding from the FP7-Health Program (grant agreement no. 278955).

© Micronit 2014 | all rights reserved | disclaimer